1. Home
  2. TVTX vs FBNC Comparison

TVTX vs FBNC Comparison

Compare TVTX & FBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • FBNC
  • Stock Information
  • Founded
  • TVTX 2008
  • FBNC 1934
  • Country
  • TVTX United States
  • FBNC United States
  • Employees
  • TVTX N/A
  • FBNC N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • FBNC Major Banks
  • Sector
  • TVTX Health Care
  • FBNC Finance
  • Exchange
  • TVTX Nasdaq
  • FBNC Nasdaq
  • Market Cap
  • TVTX 2.3B
  • FBNC 2.2B
  • IPO Year
  • TVTX N/A
  • FBNC N/A
  • Fundamental
  • Price
  • TVTX $27.32
  • FBNC $47.70
  • Analyst Decision
  • TVTX Strong Buy
  • FBNC Buy
  • Analyst Count
  • TVTX 16
  • FBNC 4
  • Target Price
  • TVTX $35.20
  • FBNC $56.67
  • AVG Volume (30 Days)
  • TVTX 1.7M
  • FBNC 213.1K
  • Earning Date
  • TVTX 10-30-2025
  • FBNC 10-24-2025
  • Dividend Yield
  • TVTX N/A
  • FBNC 1.93%
  • EPS Growth
  • TVTX N/A
  • FBNC N/A
  • EPS
  • TVTX N/A
  • FBNC 2.35
  • Revenue
  • TVTX $333,865,000.00
  • FBNC $361,053,000.00
  • Revenue This Year
  • TVTX $84.12
  • FBNC $36.30
  • Revenue Next Year
  • TVTX $40.82
  • FBNC $8.19
  • P/E Ratio
  • TVTX N/A
  • FBNC $20.31
  • Revenue Growth
  • TVTX 87.94
  • FBNC N/A
  • 52 Week Low
  • TVTX $12.91
  • FBNC $34.50
  • 52 Week High
  • TVTX $28.69
  • FBNC $56.45
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 68.86
  • FBNC 34.01
  • Support Level
  • TVTX $25.09
  • FBNC $45.96
  • Resistance Level
  • TVTX $28.00
  • FBNC $51.36
  • Average True Range (ATR)
  • TVTX 1.13
  • FBNC 1.52
  • MACD
  • TVTX -0.04
  • FBNC -0.50
  • Stochastic Oscillator
  • TVTX 85.67
  • FBNC 22.28

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About FBNC First Bancorp

First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing and investment advisory services.

Share on Social Networks: